Predictive value of brachial reactive hyperemia and flow-mediated dilation in stable coronary artery disease

Clin Hemorheol Microcirc. 2014;56(3):247-57. doi: 10.3233/CH-131720.

Abstract

Background: The purpose of this study was to determine the predictive value of a single measurement of reactive hyperemia (RH) and brachial flow-mediated dilation (FMD) in patients with established stable coronary artery disease (CAD).

Methods: RH and brachial artery FMD were ultrasonographically measured in 325 patients with stable CAD. Patients were followed for cerebro-cardiovascular events. The median follow-up was 3.7 years (range 0.01-5.7 years).

Results: Sixty-seven patients (20.6%) had an cerebro-cardiovascular event. Patients with subsequent events had lower FMD (4.9 ± 3.3% versus 6.3 ± 3.5%, p = 0.003), higher brachial artery resting diameter (5.1 ± 0.7 mm versus 4.8 ± 0.7 mm, p = 0.002) and lower NMD (11.2 ± 5.1% versus 12.8 ± 5.4%, p = 0.02), while the mean hyperemic flow velocity and shear stress did not differ from patients without cerebro-cardiovascular events. Cox proportional hazard model adjusted for sex, age, BMI, and traditional cardiovascular risk factors revealed a hazard ratio of 0.84 for lower FMD (p = 0.01).

Conclusions: We conclude that single spot measurements of peak RH do not provide long-term prognostic information, but evaluation of conduit artery FMD predicts long-term cerebro-cardiovascular events in patients with stable CAD. The prognostic value of FMD is incremental to traditional cardiovascular risk factors and may therefore be of clinical importance.

Keywords: Endothelium; coronary artery disease; flow-mediated dilation; reactive hyperemia; shear stress.

MeSH terms

  • Blood Flow Velocity
  • Brachial Artery / pathology*
  • Coronary Artery Disease
  • Female
  • Humans
  • Hyperemia / metabolism*
  • Male
  • Middle Aged
  • Prognosis
  • Risk Factors